COSMOS HEALTH INC (COSM)
US2214133058 - Common Stock
Overall COSM gets a fundamental rating of 3 out of 10. We evaluated COSM against 118 industry peers in the Health Care Providers & Services industry. While COSM seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, COSM is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
COSM had negative earnings in the past year.
COSM had a negative operating cash flow in the past year.
In the past 5 years COSM reported 4 times negative net income.
COSM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
COSM has a Return On Assets of -59.98%. This is amonst the worse of the industry: COSM underperforms 89.66% of its industry peers.
Looking at the Return On Equity, with a value of -96.27%, COSM is doing worse than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.98% | ||
| ROE | -96.27% | ||
| ROIC | N/A |
ROA(3y)-41.22%
ROA(5y)-36.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 7.19%, COSM is not doing good in the industry: 80.17% of the companies in the same industry are doing better.
COSM's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for COSM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 7.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.67%
GM growth 5Y12.63%
2. Health
2.1 Basic Checks
COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COSM has more shares outstanding
Compared to 5 years ago, COSM has more shares outstanding
Compared to 1 year ago, COSM has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.77, we must say that COSM is in the distress zone and has some risk of bankruptcy.
COSM's Altman-Z score of -0.77 is on the low side compared to the rest of the industry. COSM is outperformed by 70.69% of its industry peers.
COSM has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
COSM has a Debt to Equity ratio of 0.20. This is in the better half of the industry: COSM outperforms 71.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.77 |
ROIC/WACCN/A
WACC6%
2.3 Liquidity
COSM has a Current Ratio of 2.06. This indicates that COSM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.06, COSM is in the better half of the industry, outperforming 76.72% of the companies in the same industry.
COSM has a Quick Ratio of 1.79. This is a normal value and indicates that COSM is financially healthy and should not expect problems in meeting its short term obligations.
COSM has a better Quick ratio (1.79) than 71.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 82.89% over the past year.
Looking at the last year, COSM shows a decrease in Revenue. The Revenue has decreased by -8.99% in the last year.
The Revenue has been growing by 10.90% on average over the past years. This is quite good.
EPS 1Y (TTM)82.89%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q86.15%
Revenue 1Y (TTM)-8.99%
Revenue growth 3Y8.26%
Revenue growth 5Y10.9%
Revenue growth Q2Q6.69%
3.2 Future
Based on estimates for the next years, COSM will show a very strong growth in Earnings Per Share. The EPS will grow by 40.91% on average per year.
The Revenue is expected to grow by 13.85% on average over the next years. This is quite good.
EPS Next Y98.03%
EPS Next 2Y40.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y13.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for COSM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for COSM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
COSM's earnings are expected to grow with 40.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.91%
EPS Next 3YN/A
5. Dividend
5.1 Amount
COSM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
COSMOS HEALTH INC
NASDAQ:COSM (5/3/2024, 7:00:00 PM)
After market: 0.6178 -0.06 (-9.15%)0.68
+0 (+0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.51M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.98% | ||
| ROE | -96.27% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 7.19% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.79 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)82.89%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y98.03%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.99%
Revenue growth 3Y8.26%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y